KCNQ2 and epilepsy: Identification of KCNQ2 and KCNQ3 genes mutations as the molecular cause of benign familial neonatal seizures (BFNS; an autosomal dominant idiopathic epilepsy syndrome of newborns, characterized by unprovoked partial seizures typically beginning at the age of around three days), supported the position of those channels as drug targets in epilepsy.